R&D 4 years on: Remembering the COVID-19 pandemic This year, Monday 11th March marked four years since the World Health Organization (WHO) declared COVID-19 a global pandemic.
Patients Protecting the immunocompromised: Preventative measures agai... COVID-19 vaccines are not as effective in immunocompromised individuals as they are in the general population, due to an inability to produce a robust protective response to the vaccine.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
